Evidence map›Paper›PMID 38800333›Full record

ArticleCureus2024

Direct Species Identification in Positive Blood Culture Bottles From Patients With Hematologic Malignancies.

Noriyuki Watanabe, Sachie Koyama, Tomoya Maeda, Haruka Karaushi, Yoshitada Taji, Yohei Kawasaki, Naoki Takahashi, Kotaro Mitsutake, Yasuhiro Ebihara

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Noriyuki WatanabeClinical Laboratory, Saitama Medical University International Medical Center, Saitama, JPN.
Sachie KoyamaClinical Laboratory, Saitama Medical University International Medical Center, Saitama, JPN.
Tomoya MaedaDepartment of Hemato-Oncology, Saitama Medical University International Medical Center, Saitama, JPN.
Haruka KaraushiDepartment of Infectious Diseases and Infection Control, Saitama Medical University International Medical Center, Saitama, JPN.
Yoshitada TajiClinical Laboratory, Saitama Medical University International Medical Center, Saitama, JPN.
Yohei KawasakiDepartment of Biostatistics, Graduate School of Medicine, Saitama Medical University, Saitama, JPN.
Naoki TakahashiDepartment of Hemato-Oncology, Saitama Medical University International Medical Center, Saitama, JPN.
Kotaro MitsutakeDepartment of Infectious Diseases and Infection Control, Saitama Medical University International Medical Center, Saitama, JPN.
Yasuhiro EbiharaDepartment of Laboratory Medicine, Saitama Medical University International Medical Center, Saitama, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background In patients with hematologic malignancies, faster species identification is particularly important in the management of bloodstream infection because of their immunocompromised and neutropenic status. In the present study, we analyzed direct species identification in patients with hematologic malignancies, and the factors that might influence the results of species identification. Methods We performed direct species identification using a Sepsityper

Indexed as

blood culturebloodstream infectioncentral venous linedirect species identificationhematologic malignancy

Identifiers

PMID38800333
PMCPMC11128060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.